Classification of angioedema types using decision tree modeling

  • Felix Aulenbacher
  • , Annika Gutsche
  • , Henriette Farkas
  • , Kinga Viktória Kőhalmi
  • , Emek Kocatürk
  • , Emel Aygören-Pürsün
  • , Ludovic Martin
  • , Hilary Longhurst
  • , Petra Staubach
  • , Andrea Zanichelli
  • , Werner Aberer
  • , Anette Bygum
  • , Mignon van den Elzen
  • , Thomas Buttgereit
  • , Markus Magerl*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Introduction: All angioedema (AE) presents with transient, localized swelling; however, the underlying causes, prognosis, and treatments vary significantly. Consequently, identifying a specific AE type is challenging. Methods: We aimed to apply a machine learning (ML) model to improve AE diagnosis. Random forest (RF) ML was used to create a prediction model for diagnosing correct AE types. Development comprised a literature search to establish AE's clinical characteristics, developing and translating questions in collaboration with 12 European AE centers, and selecting, testing, validating and optimizing the established ML model. Analysis included 342 specialist-diagnosed patients with one of six AE types. Results: The final optimized RF model correctly identified AE types with true positive rates of up to 94% in hereditary AE due to C1 inhibitor deficiency (C1INH), with a Percentage Accuracy of 89·2% and a Kappa value of 81·8% across the six AE types, with a high agreement with the diagnoses made by experts. Discussion: This is the first ever reported ML algorithm designed to pre-assess to aid AE diagnosis.

Original languageEnglish
Article number1697143
JournalFrontiers in Immunology
Volume16
DOIs
Publication statusPublished - 2026

Keywords

  • angioedema
  • bradykinin-mediated angioedema
  • clinical decision support
  • diagnostic classification
  • hereditary angioedema
  • machine learning
  • mast cell-mediated angioedema
  • Random Forest

Fingerprint

Dive into the research topics of 'Classification of angioedema types using decision tree modeling'. Together they form a unique fingerprint.

Cite this